Life Science Disruptors →
Nobel Laureate, Professor of Biology, Caltech
CEO and Fund Manager, Renaissance Venture Capital Fund
CEO of Project Foundry
Founder, Young Inventors
Founding Director, Massachusetts Technology Transfer Center
President & CEO, Indiana Biosciences Research Institute
CEO and Founder, Techstars
September 26, 2017 ·
September 28, 2017 ·
November 2, 2017 ·
Sponsored · Whitepaper
Moreover, more than half of Fortune 500 pharmaceutical and medica
Reduce turnaround times, cut excessive admin expenses and increas
The pressure has never been greater for life science organizations to shorten the development cycle for new drugs and devices.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.